AU2001288039A1 - Suppositories sustained in the lower rectum - Google Patents

Suppositories sustained in the lower rectum

Info

Publication number
AU2001288039A1
AU2001288039A1 AU2001288039A AU2001288039A AU2001288039A1 AU 2001288039 A1 AU2001288039 A1 AU 2001288039A1 AU 2001288039 A AU2001288039 A AU 2001288039A AU 2001288039 A AU2001288039 A AU 2001288039A AU 2001288039 A1 AU2001288039 A1 AU 2001288039A1
Authority
AU
Australia
Prior art keywords
suppositories
sustained
lower rectum
rectum
suppositories sustained
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2001288039A
Other versions
AU2001288039B2 (en
Inventor
Katsuyoshi Aikawa
Seiichi Hori
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taisho Pharmaceutical Co Ltd
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Priority claimed from PCT/JP2001/007893 external-priority patent/WO2002024161A1/en
Publication of AU2001288039A1 publication Critical patent/AU2001288039A1/en
Application granted granted Critical
Publication of AU2001288039B2 publication Critical patent/AU2001288039B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2001288039A 2000-09-21 2001-09-12 Suppositories sustained in the lower rectum Ceased AU2001288039B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000-286963 2000-09-21
JP2000286963 2000-09-21
PCT/JP2001/007893 WO2002024161A1 (en) 2000-09-21 2001-09-12 Suppositories sustained in the lower rectum

Publications (2)

Publication Number Publication Date
AU2001288039A1 true AU2001288039A1 (en) 2002-06-20
AU2001288039B2 AU2001288039B2 (en) 2005-09-15

Family

ID=18770792

Family Applications (2)

Application Number Title Priority Date Filing Date
AU8803901A Pending AU8803901A (en) 2000-09-21 2001-09-12 Suppositories sustained in the lower rectum
AU2001288039A Ceased AU2001288039B2 (en) 2000-09-21 2001-09-12 Suppositories sustained in the lower rectum

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU8803901A Pending AU8803901A (en) 2000-09-21 2001-09-12 Suppositories sustained in the lower rectum

Country Status (8)

Country Link
US (1) US7022335B2 (en)
EP (1) EP1319397B1 (en)
JP (1) JP5082181B2 (en)
AT (1) ATE301988T1 (en)
AU (2) AU8803901A (en)
CA (1) CA2422356C (en)
DE (1) DE60112772T2 (en)
WO (1) WO2002024161A1 (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
KR101108439B1 (en) 2002-10-25 2012-01-31 포믹스 리미티드 Cosmetic and pharmaceutical foam
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US20070292355A1 (en) * 2002-10-25 2007-12-20 Foamix Ltd. Anti-infection augmentation foamable compositions and kit and uses thereof
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
KR100733028B1 (en) * 2003-08-29 2007-06-28 사토 세이야쿠 가부시키가이샤 Preparation for rectal administration
JP2005314241A (en) * 2004-04-27 2005-11-10 Tendou Seiyaku Kk Suppository base controlling occurrence of crack/fragment and method for producing the same
US9238073B2 (en) 2006-04-12 2016-01-19 Wyeth Llc Pharmaceutical composition containing sympathomimetic amine salt and co-distillable additive
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
JP5223307B2 (en) * 2006-11-17 2013-06-26 大正製薬株式会社 Suppository
ITMI20070084A1 (en) * 2007-01-22 2008-07-23 Carlo Ghisalberti LIPID BASED VAGINAL ANTISEPTIC DEVICES
JP5217530B2 (en) * 2007-03-15 2013-06-19 大正製薬株式会社 Suppository
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
WO2009069006A2 (en) 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
WO2009090495A2 (en) 2007-12-07 2009-07-23 Foamix Ltd. Oil and liquid silicone foamable carriers and formulations
CA2760186C (en) 2009-04-28 2019-10-29 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
CA2769625C (en) 2009-07-29 2017-04-11 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013008A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
MX359879B (en) 2009-10-02 2018-10-12 Foamix Pharmaceuticals Ltd Topical tetracycline compositions.
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US9545391B2 (en) * 2010-08-11 2017-01-17 Hemaway Llc Medicated ointment for treating hemorrhoid and method of using the same
JP5892658B2 (en) * 2010-08-20 2016-03-23 国立大学法人 東京医科歯科大学 Pharmaceutical composition for transcolon absorption
EP3267976A1 (en) 2015-03-12 2018-01-17 Cristcot Llc Hydrocortisone acetate suppository formulation for treatment of disease
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
CA3087720C (en) * 2018-01-08 2023-03-07 Qi Liu Rectal mucosal administration preparation of pulsatilla chinensis saponin b4 and preparation method therefor
US11576801B2 (en) 2019-01-24 2023-02-14 Robert S. Cutler Topical treatment for anorectal disorders with and without seat cushion

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE291247C (en)
US2055063A (en) * 1935-11-25 1936-09-22 Hoffmann La Roche Suppository medication
US4722941A (en) * 1978-06-07 1988-02-02 Kali-Chemie Pharma Gmbh Readily absorbable pharmaceutical compositions of per se poorly absorbable pharmacologically active agents and preparation thereof
SU1364339A1 (en) 1980-02-25 1988-01-07 Всесоюзный Научно-Исследовательский Институт Жиров Base for suppository
JPS56131514A (en) * 1980-03-17 1981-10-15 Nissan Chem Ind Ltd Ketoprofen composition for rectum administration
JPH0676314B2 (en) * 1985-09-30 1994-09-28 花王株式会社 Suppository base and suppository
DD291247A5 (en) * 1989-12-29 1991-06-27 Veb Jenapharm,De PROCESS FOR THE PREPARATION OF SUPPOSITORIES WITH IMPROVED DRUG DISTRIBUTION
JP3467628B2 (en) 1991-05-24 2003-11-17 岩城製薬株式会社 Suppository base
TW359614B (en) * 1993-08-31 1999-06-01 Takeda Chemical Industries Ltd Composition containing benzimidazole compounds for rectal administration
JPH07196516A (en) * 1993-12-29 1995-08-01 Senju Pharmaceut Co Ltd Therapeutic agent for hemorrhoids
JP4651132B2 (en) * 1995-09-07 2011-03-16 大正製薬株式会社 Composition for continuous rectal administration
CN1132573C (en) 1995-09-07 2003-12-31 大正制药株式会社 Long-lasting composition for rectal administration
RU2128987C1 (en) * 1997-04-22 1999-04-20 Открытое акционерное общество "Нижегородский химико-фармацевтический завод" Rectal suppositories for treatment of pediatric patients
US5760023A (en) * 1997-07-14 1998-06-02 Adolor Corporation Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith
CA2305761A1 (en) * 1997-10-08 1999-04-15 Taisho Pharmaceutical Co., Ltd. Composition for suppositories

Similar Documents

Publication Publication Date Title
AU2001288039A1 (en) Suppositories sustained in the lower rectum
AU2001291238A1 (en) Portable urinal
MXPA03000183A (en) Glucocortiocoid-selective antiinflammatory agents.
TW454886U (en) Pivot structure
AU2002222485A1 (en) Multi-purpose structure
AU2002224876A1 (en) Isolated luciferases and the use thereof
AU2001262263A1 (en) Line arrangement
AU6226301A (en) Line arrangement
GB2365277B (en) Portable telephone with orininator-acknowledge function
AU2002237014A1 (en) The multi-functional pda
AU2001232112A1 (en) Improvements in burner construction
AU6286101A (en) New use
AU7463401A (en) Can with sanitary lid-on
AU2001285246A1 (en) Search-on-the-fly with merge function
AU2001256680A1 (en) Hiv-producing cell line and use thereof
AU2002224528A1 (en) New use
AU2001277689A1 (en) The easy-parker-indicator
AU2002223468A1 (en) Dual shower in three designs
AU2001232578A1 (en) New use
GB0029592D0 (en) The double line
GB0019704D0 (en) Cell line
GB0026942D0 (en) Cell line
IL134765A0 (en) Portable toilet
CA90761S (en) Calculator
CA89308S (en) Calculator